| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10620-008-0209-Y |
| P8608 | Fatcat ID | release_xg5jnuexx5azrm65dwalqsg4fa |
| P698 | PubMed publication ID | 18320314 |
| P2093 | author name string | Jawad Ahmad | |
| Kathy K Downey | |||
| Mahathi Adla | |||
| P2860 | cites work | Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 |
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Cutaneous, pulmonary and hepatic sarcoidosis associated with autoimmune complications during interferon-alpha treatment for hepatitis C virus infection | Q33371011 | ||
| Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature | Q34761943 | ||
| Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature | Q35088587 | ||
| Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature | Q36199456 | ||
| Sarcoidosis-associated hepatitis C virus infection | Q43980765 | ||
| Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. | Q47809437 | ||
| Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C. | Q47913375 | ||
| Cutaneous sarcoidosis limited to scars following pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C. | Q50574124 | ||
| [Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature] | Q50581957 | ||
| Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. | Q50584280 | ||
| Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. | Q50584975 | ||
| Pegylated interferon alfa-induced sarcoidosis: two sides of the same coin | Q81433149 | ||
| Interferon-induced sarcoidosis | Q82442869 | ||
| P433 | issue | 10 | |
| P921 | main subject | interferon alfa | Q6046441 |
| pegylated interferon | Q7160835 | ||
| hepatitis C | Q154869 | ||
| case report | Q2782326 | ||
| chronic hepatitis C | Q55779873 | ||
| chronic hepatitis | Q62019625 | ||
| P304 | page(s) | 2810-2812 | |
| P577 | publication date | 2008-03-05 | |
| P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
| P1476 | title | Hepatic sarcoidosis associated with pegylated interferon alfa therapy for chronic hepatitis C: case report and review of literature | |
| P478 | volume | 53 |
| Q50273726 | Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction |
| Q37845903 | Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature |
| Q26822834 | Hepatic Sarcoidosis |
| Q42972531 | Hepatic sarcoidosis complicating treatment-naive viral hepatitis. |
| Q37406596 | Interferons and their potential in the treatment of ocular inflammation |
| Q33891019 | Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C. |
Search more.